1. Home
  2. ODFL vs ONC Comparison

ODFL vs ONC Comparison

Compare ODFL & ONC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Old Dominion Freight Line Inc.

ODFL

Old Dominion Freight Line Inc.

N/A

Current Price

$178.12

Market Cap

36.8B

Sector

Industrials

ML Signal

N/A

Logo BeiGene Ltd. American Depositary Shares

ONC

BeiGene Ltd. American Depositary Shares

N/A

Current Price

$358.81

Market Cap

40.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ODFL
ONC
Founded
1934
2010
Country
United States
Switzerland
Employees
N/A
12000
Industry
Trucking Freight/Courier Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
36.8B
40.6B
IPO Year
1996
2015

Fundamental Metrics

Financial Performance
Metric
ODFL
ONC
Price
$178.12
$358.81
Analyst Decision
Buy
Strong Buy
Analyst Count
25
28
Target Price
$228.78
★ $432.80
AVG Volume (30 Days)
★ 1.5M
320.8K
Earning Date
10-28-2026
11-10-2026
Dividend Yield
★ 0.67%
N/A
EPS Growth
N/A
★ 140.43
EPS
★ 2.82
0.31
Revenue
★ $5,496,389,000.00
$238,387,000.00
Revenue This Year
$7.60
$26.33
Revenue Next Year
$7.86
$14.36
P/E Ratio
★ $63.11
$1,196.77
Revenue Growth
N/A
★ 22179.16
52 Week Low
$126.01
$253.95
52 Week High
$252.03
$385.22

Technical Indicators

Market Signals
Indicator
ODFL
ONC
Relative Strength Index (RSI) 33.74 60.26
Support Level $169.21 $327.01
Resistance Level $180.72 $380.00
Average True Range (ATR) 4.38 6.86
MACD 0.96 0.75
Stochastic Oscillator 31.15 87.88

Price Performance

Historical Comparison
ODFL
ONC

About ODFL Old Dominion Freight Line Inc.

Old Dominion Freight Line is the second-largest less-than-truckload carrier in the United States (following FedEx Freight), with roughly 260 service centers and 11,000-plus tractors. It is one of the most disciplined and efficient providers in the trucking industry, and its profitability and capital returns are well above those of its peers. Strategic initiatives focus on increasing network density through market-share gains and on maintaining industry-leading service (including ultralow cargo claims) through steadfast infrastructure investment.

About ONC BeiGene Ltd. American Depositary Shares

Formerly known as BeiGene and founded in 2010 in Beijing, BeOne is a commercial-stage biotech firm that produces oncology therapeutics. The company's main product is Brukinsa, which is a small-molecule drug that treats multiple forms of Non-Hodgkin lymphoma and leukemia. The company conducts drug discovery, runs global clinical trials, and manufactures drugs independently. As of 2025, Brukinsa made up for 74% of total revenue, while it has two other approved commercialized drugs in its portfolio, Beqalzi and Tevimbra. While Brukinsa has a global leadership, the other two drugs generate revenue mostly from China. Based on Brukinsa, BeOne competes with AbbVie and AstraZeneca mainly. The company also has more than 50 drugs in clinical trials in its active pipeline, focused on other cancers.

Share on Social Networks: